Regeneron Pharmaceuticals, Inc. (LON: 0R2M)
London
· Delayed Price · Currency is GBP · Price in USD
713.88
+6.59 (0.93%)
Dec 23, 2024, 6:40 PM BST
Regeneron Pharmaceuticals Employees
Regeneron Pharmaceuticals had 13,450 employees as of December 30, 2023. The number of employees increased by 1,599 or 13.49% compared to the previous year.
Employees
13,450
Change (1Y)
1,599
Growth (1Y)
13.49%
Revenue / Employee
729.36K GBP
Profits / Employee
245.16K GBP
Market Cap
60.06B
Employees Chart
Employees History
Regeneron Pharmaceuticals News
- 4 days ago - Regeneron reports positive results for two anti-coagulant drugs - Seeking Alpha
- 4 days ago - Regeneron Pharmaceuticals Inc (REGN) Announces Positive Phase 2 Results for Novel ... - GuruFocus
- 4 days ago - Regeneron to Advance Two Factor XI Antibodies into a Broad Phase 3 Program Following Positive Phase 2 Proof-of-concept Results - GlobeNewsWire
- 5 days ago - Regeneron Announces Presentation at the 43rd Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 6 days ago - Regeneron's Best-Selling Eye Drug Eylea's Higher Dose Formulation Meets Primary Goal In Another Form Of Retinal Disease Study - Benzinga
- 6 days ago - Regeneron posts Phase 3 win for Eylea HD in retinal vein occlusion - Seeking Alpha
- 6 days ago - Regeneron Pharmaceuticals Inc (REGN) Announces Positive Phase 3 Trial Results for EYLEA HD - GuruFocus
- 6 days ago - Regeneron Pharmaceuticals Inc (REGN) Achieves High Sustainability Rankings - GuruFocus